In June 2020, a group of international researchers followed the invitation of the Medical University of Vienna and the LBI for Hematology and Oncology to discuss the newest developments in Cell Therapies and Stem Cells in AML and CML.

Due to the COVID-19 outbreak the meeting had to be changed to an online-only format on short notice, which was a premiere for the event organizers at the LBI HO. Nonetheless, the meeting was a great success and the online video format proved to work very well for all participants and speakers alike.

The one-day meeting included sessions on target expression profiles, stem cell transplantation, novel immunotherapy-concepts, and stem cell resistance. Further, updates on networking possibilities and co-operations were shared.